Antimalarial drug use in general populations of tropical Africa
Open Access
- 8 July 2008
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 7 (1) , 124
- https://doi.org/10.1186/1475-2875-7-124
Abstract
The burden of Plasmodium falciparum malaria has worsened because of the emergence of chloroquine resistance. Antimalarial drug use and drug pressure are critical factors contributing to the selection and spread of resistance. The present study explores the geographical, socio-economic and behavioural factors associated with the use of antimalarial drugs in Africa. The presence of chloroquine (CQ), pyrimethamine (PYR) and other antimalarial drugs has been evaluated by immuno-capture and high-performance liquid chromatography in the urine samples of 3,052 children (2–9 y), randomly drawn in 2003 from the general populations at 30 sites in Senegal (10), Burkina-Faso (10) and Cameroon (10). Questionnaires have been administered to the parents of sampled children and to a random sample of households in each site. The presence of CQ in urine was analysed as dependent variable according to individual and site characteristics using a random – effect logistic regression model to take into account the interdependency of observations made within the same site. According to the sites, the prevalence rates of CQ and PYR ranged from 9% to 91% and from 0% to 21%, respectively. In multivariate analysis, the presence of CQ in urine was significantly associated with a history of fever during the three days preceding urine sampling (OR = 1.22, p = 0.043), socio-economic level of the population of the sites (OR = 2.74, p = 0.029), age (2–5 y = reference level; 6–9 y OR = 0.76, p = 0.002), prevalence of anti-circumsporozoite protein (CSP) antibodies (low prevalence: reference level; intermediate level OR = 2.47, p = 0.023), proportion of inhabitants who lived in another site one year before (OR = 2.53, p = 0.003), and duration to reach the nearest tarmacked road (duration less than one hour = reference level, duration equal to or more than one hour OR = 0.49, p = 0.019). Antimalarial drug pressure varied considerably from one site to another. It was significantly higher in areas with intermediate malaria transmission level and in the most accessible sites. Thus, P. falciparum strains arriving in cross-road sites or in areas with intermediate malaria transmission are exposed to higher drug pressure, which could favour the selection and the spread of drug resistance.Keywords
This publication has 32 references indexed in Scilit:
- Impact of Artemisinin-Based Combination Therapy and Insecticide-Treated Nets on Malaria Burden in ZanzibarPLoS Medicine, 2007
- Assessing malaria control in the Kassena-Nankana district of northern Ghana through repeated surveys using the RBM toolsMalaria Journal, 2007
- Age Interactions in the Development of Naturally Acquired Immunity to Plasmodium falciparum and Its Clinical PresentationPLoS Medicine, 2007
- Choice of treatment for fever at household level in Malawi: examining spatial patternsMalaria Journal, 2007
- Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors?Transactions of the Royal Society of Tropical Medicine and Hygiene, 2002
- Combating malaria in AfricaTrends in Parasitology, 2002
- Incidence and management of malaria in two communities of different socio–economic level, in Accra, GhanaPathogens and Global Health, 2000
- Combating malaria morbidity and mortality by reducing transmissionParasitology Today, 1996
- Host Age as a determinant of naturally acquired immunity to Plasmodium falciparumParasitology Today, 1995
- Use of micro samples of finger prick blood dried on filter paper for a quick and simple dipstick dot-EIA for diagnosis of amebic liver abscess (ALA)Journal of Clinical Laboratory Analysis, 1994